Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Routine: DVBCWPW1

DVBCWPW1.m

Go to the documentation of this file.
  1. DVBCWPW1 ;ALB/CMM PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 6 MARCH 1997
  1. ;;2.7;AMIE;**12**;Apr 10, 1995
  1. ;
  1. ;
  1. TXT ;
  1. ;;A. Review of Medical Records:
  1. ;;
  1. ;;
  1. ;;
  1. ;;B. Medical History (Subjective Complaints):
  1. ;;
  1. ;; Comment on:
  1. ;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
  1. ;;
  1. ;;
  1. ;; 2. Date of inactivity if it is not active.
  1. ;;
  1. ;;
  1. ;; 3. Identity of organism (if possible).
  1. ;;
  1. ;;
  1. ;;C. Physical examination (Objective Findings):
  1. ;;
  1. ;; Address each of the following and fully describe current findings:
  1. ;; 1. Extent of structural damage to lungs.
  1. ;;
  1. ;;
  1. ;; 2. If patient was hospitalized for 6 months or more, what is the
  1. ;; condition at the end of hospitalization?
  1. ;;
  1. ;;
  1. ;; 3. If patient was hospitalized for 12 months or more, what is the
  1. ;; condition at the end of hospitalization?
  1. ;;
  1. ;;
  1. ;;D. Diagnostic and Clinical Tests:
  1. ;;
  1. ;; Provide:
  1. ;; Pulmonary Function Tests, if indicated. When the results of
  1. ;; pre-bronchodilator pulmonary function tests are NORMAL, post-
  1. ;; bronchodilator studies are not required for VA evaluation purposes.
  1. ;; IN ALL OTHER CASES, post-bronchodilator studies shuld be conducted
  1. ;; unless contraindicated (because of allergy to medication, etc.) or
  1. ;; if the veteran was on bronchodilators before the test and had taken
  1. ;; his or her medication within a few hours of the study. An examiner
  1. ;; who determines that a post-bronchodilator study should not be
  1. ;; performed should provide an explanation of why not. If there is
  1. ;; a disparity between the results of different pulmonary function
  1. ;; tests (FEV-1, FVC, etc.), the examiner should indicate which test
  1. ;; result is the best indicator of the veteran's level of pulmonary
  1. ;; functioning.
  1. ;;
  1. ;;
  1. ;;E. Diagnosis:
  1. ;;
  1. ;; In reactivated cases, is this reactivation of the old disease or a
  1. ;; separate and distinct new infection.
  1. ;;
  1. ;;
  1. ;;
  1. ;;ADDITIONAL NOTE TO THE PHYSICIAN:
  1. ;;In all claims, if the disease is inactive and if the inactivity was
  1. ;;confirmed at a non-VA facility, obtain the name and mailing address of
  1. ;;the facility from the veteran so that the Regional Office may request
  1. ;;the report.
  1. ;;
  1. ;;
  1. ;;Signature: Date:
  1. ;;END